|
Q2 FY2026
As of Jul 3, 2026
|
Q1 FY2026
As of Apr 3, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Oct 3, 2025
|
Q2 FY2025
As of Jul 4, 2025
|
Q1 FY2025
As of Apr 4, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 27, 2024
|
Q2 FY2024
As of Jun 28, 2024
|
Q1 FY2024
As of Mar 29, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 29, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jul 1, 2022
|
Q1 FY2022
As of Apr 1, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Trade receivables, less allowance for credit losses of $22,538 and $21,765 | ||||||||||||||||||
| Inventories, net | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Lease assets - right of use | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Long-Term Debt, Current Maturities | ||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Long-term debt | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||
| Equity: | ||||||||||||||||||
| 6.50% Series A Mandatory Convertible Preferred Stock, 175,000 shares issued and outstanding at July 3, 2026; no shares issued or outstanding at December 31, 2025 | ||||||||||||||||||
| Common stock - $0.001 par value - 600,000,000 shares authorized, 62,167,669 and 60,721,079 shares outstanding as of July 3, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Total ESAB Corporation equity | ||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||
| Total equity | ||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||
Loading...
